Case Reports
27 May 2013

Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
3111
Views
847
Downloads

Authors

Systemic sclerosis is an inflammatory disease of the connective tissue characterized by vasculopathy and accumulation of collagen and other components of the connective matrix, affecting the skin and internal organs. The appearance of skin ulcers as a result of vascular damage is very common in the history of the disease. Skin ulcers, painful and slow healing due to atrophy and local ischemia, get worse the quality of life of patients. Often, the use of conventional therapies (such as calcium channel blockers and prostanoids) does not cause the complete healing of the lesions. We report the case of a patient in whom therapeutic association between endothelin antagonist (bosentan) and phosphodiesterase-V inhibitor (sildenafil) resulted in complete healing of old ulcers both to upper and lower limbs and allowed the interruption of intravenous therapies.

Altmetrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

none

How to Cite



Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers. (2013). Reumatismo, 65(2), 79-81. https://doi.org/10.4081/reumatismo.2013.79